These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25407485)

  • 61. Yeast-Based Screens to Target Alpha-Synuclein Toxicity.
    Brás IC; Popova B; Braus GH; Outeiro TF
    Methods Mol Biol; 2019; 1948():145-156. PubMed ID: 30771176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanism of prion loss after Hsp104 inactivation in yeast.
    Wegrzyn RD; Bapat K; Newnam GP; Zink AD; Chernoff YO
    Mol Cell Biol; 2001 Jul; 21(14):4656-69. PubMed ID: 11416143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Motility and segregation of Hsp104-associated protein aggregates in budding yeast.
    Zhou C; Slaughter BD; Unruh JR; Eldakak A; Rubinstein B; Li R
    Cell; 2011 Nov; 147(5):1186-96. PubMed ID: 22118470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Avidity for Polypeptide Binding by Nucleotide-Bound Hsp104 Structures.
    Weaver CL; Duran EC; Mack KL; Lin J; Jackrel ME; Sweeny EA; Shorter J; Lucius AL
    Biochemistry; 2017 Apr; 56(15):2071-2075. PubMed ID: 28379007
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity.
    Kryndushkin D; Ihrke G; Piermartiri TC; Shewmaker F
    Mol Microbiol; 2012 Dec; 86(6):1531-47. PubMed ID: 23078282
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radicicol rescues yeast cell death triggered by expression of human α-synuclein and its A53T mutant, but not by human βA4 peptide and proapoptotic protein bax.
    Derf A; Verekar SA; Jain SK; Deshmukh SK; Bharate SB; Chaudhuri B
    Bioorg Chem; 2019 Apr; 85():152-158. PubMed ID: 30612081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced Activity.
    Mack KL; Shorter J
    Front Mol Biosci; 2016; 3():8. PubMed ID: 27014702
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Remodeling of protein aggregates by Hsp104.
    Glover JR; Lum R
    Protein Pept Lett; 2009; 16(6):587-97. PubMed ID: 19519516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interaction of Hsp104 with yeast prion Sup35 as analyzed by fluorescence cross-correlation spectroscopy.
    Ohta S; Kawai-Noma S; Kitamura A; Pack CG; Kinjo M; Taguchi H
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):28-32. PubMed ID: 24216111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hsp104 as a key modulator of prion-mediated oxidative stress in Saccharomyces cerevisiae.
    Singh K; Saleh AA; Bhadra AK; Roy I
    Biochem J; 2013 Sep; 454(2):217-25. PubMed ID: 23746301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology.
    Sprunger ML; Lee K; Sohn BS; Jackrel ME
    iScience; 2022 Mar; 25(3):103900. PubMed ID: 35252808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of Cytotoxicity of α-Synuclein in Budding Yeast Using a Spot Growth Assay and Fluorescent Microscopy.
    Takaine M
    Methods Mol Biol; 2021; 2322():163-174. PubMed ID: 34043202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease.
    Jackrel ME; Shorter J
    Front Neurosci; 2017; 11():99. PubMed ID: 28293166
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Confinement to organelle-associated inclusion structures mediates asymmetric inheritance of aggregated protein in budding yeast.
    Spokoini R; Moldavski O; Nahmias Y; England JL; Schuldiner M; Kaganovich D
    Cell Rep; 2012 Oct; 2(4):738-47. PubMed ID: 23022486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model.
    Bonanomi M; Visentin C; Invernizzi G; Tortora P; Regonesi ME
    PLoS One; 2015; 10(6):e0129727. PubMed ID: 26052945
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Using reporters of different misfolded proteins reveals differential strategies in processing protein aggregates.
    Schneider KL; Ahmadpour D; Keuenhof KS; Eisele-Bürger AM; Berglund LL; Eisele F; Babazadeh R; Höög JL; Nyström T; Widlund PO
    J Biol Chem; 2022 Nov; 298(11):102476. PubMed ID: 36096201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. From Yeast to Patients: The Audacity and Vision of Susan Lindquist.
    Khurana V; Chung CY; Tardiff DF
    Cell Syst; 2017 Feb; 4(2):147-148. PubMed ID: 28231447
    [No Abstract]   [Full Text] [Related]  

  • 78. Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration.
    Shrestha A; Megeney LA
    Microb Cell; 2015 Nov; 2(12):458-465. PubMed ID: 28357271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The benefits of humanized yeast models to study Parkinson's disease.
    Franssens V; Bynens T; Van den Brande J; Vandermeeren K; Verduyckt M; Winderickx J
    Oxid Med Cell Longev; 2013; 2013():760629. PubMed ID: 23936613
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of endogenously expressed fluorescent protein fusions behaviour for protein quality control and cellular ageing research.
    Schneider KL; Wollman AJM; Nyström T; Shashkova S
    Sci Rep; 2021 Jun; 11(1):12819. PubMed ID: 34140587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.